Inovio Pharmaceuticals Inc (INO)

6.68
NASDAQ : Health Care
Prev Close 6.90
Day Low/High 6.55 / 6.91
52 Wk Low/High 5.85 / 11.69
Avg Volume 902.60K
Exchange NASDAQ
Shares Outstanding 74.06M
Market Cap 511.02M
EPS -0.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Hershey, Nvidia, Accenture, Cheniere Energy: 'Mad Money' Lightning Round

Hershey, Nvidia, Accenture, Cheniere Energy: 'Mad Money' Lightning Round

Jim Cramer is bullish on Hershey, Nvidia, Accenture, Cheniere Energy. He's bearish on Emerge Energy and Seaspan.

Stay Long, This Bull Is Strong: Cramer's 'Mad Money' Recap (Wednesday 2/15/17)

Stay Long, This Bull Is Strong: Cramer's 'Mad Money' Recap (Wednesday 2/15/17)

Don't get upended by the rhetoric. The transports are confirming, banks are solid, there's a genuine uptick in commerce and earnings are strong, says Jim Cramer.

Inovio And ApolloBio To Collaborate On Development And Commercialization Of HPV Pre-cancer Immunotherapy VGX-3100 In Greater China

Inovio And ApolloBio To Collaborate On Development And Commercialization Of HPV Pre-cancer Immunotherapy VGX-3100 In Greater China

Inovio to receive up to $50 million in upfront and near term payments and equity investment

Here's Why This Rally Is Sustainable: Cramer's 'Mad Money' Recap (Tuesday 1/24/17)

Here's Why This Rally Is Sustainable: Cramer's 'Mad Money' Recap (Tuesday 1/24/17)

Jim Cramer names a few of his favorite things: housing, bank, material and tech stocks, oil, copper and deregulation.

Chesapeake Energy, Comcast, Citigroup: 'Mad Money' Lightning Round

Chesapeake Energy, Comcast, Citigroup: 'Mad Money' Lightning Round

Jim Cramer is bullish on Chesapeake Energy and some bank stocks. But he's bearish on Inovio Pharmaceutical.

First Week Of August 2017 Options Trading For Inovio Pharmaceuticals (INO)

First Week Of August 2017 Options Trading For Inovio Pharmaceuticals (INO)

Investors in Inovio Pharmaceuticals Inc. saw new options become available this week, for the August 2017 expiration.

Inovio's Co-Founder And Chair Of Its Scientific Advisory Board Selected As A Top 20 Translational Researcher

Inovio's Co-Founder And Chair Of Its Scientific Advisory Board Selected As A Top 20 Translational Researcher

Dr. David B. Weiner recognized for his innovative medical and scientific research, which has been the basis for over 100 patents

Inovio's Cancer Immunotherapy (INO-3112) Generates T Cell Immune Responses In Tumor Tissue And Peripheral Blood In Patients With HPV-Associated Head And Neck Cancer

Inovio's Cancer Immunotherapy (INO-3112) Generates T Cell Immune Responses In Tumor Tissue And Peripheral Blood In Patients With HPV-Associated Head And Neck Cancer

Four of five study subjects in treated group show progression free survival ranging from nine to 24 months to date in phase I/IIa clinical study

Wall Street Ends With Gains as T-Mobile, B/E Aerospace Hit Highs

Wall Street Ends With Gains as T-Mobile, B/E Aerospace Hit Highs

Stocks closed with gains on Monday as T-Mobile led the Nasdaq amid better-than-expected earnings, while B/E Aerospace soared following announcement of its acquisition by Rockwell Collins.

Stocks Pare Some Gains, but Still Up on Positive Earnings, M&A

Stocks Pare Some Gains, but Still Up on Positive Earnings, M&A

Stocks stay in the green Monday as M&A and earnings reports lead the market higher, while manufacturing orders rise.

RSI Alert: Inovio Pharmaceuticals (INO) Now Oversold

RSI Alert: Inovio Pharmaceuticals (INO) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

INO Crosses Below Key Moving Average Level

INO Crosses Below Key Moving Average Level

In trading on Friday, shares of Inovio Pharmaceuticals Inc. crossed below their 200 day moving average of $8.62, changing hands as low as $8.60 per share.

First Week of INO May 2017 Options Trading

First Week of INO May 2017 Options Trading

Investors in Inovio Pharmaceuticals Inc. saw new options begin trading this week, for the May 2017 expiration.

Inovio's Zika Vaccine Selected As 2016 Technology Breakthrough

Inovio's Zika Vaccine Selected As 2016 Technology Breakthrough

Popular Mechanics magazine calls Inovio's Zika prevention a completely new form of vaccination that may be the fastest vaccine ever to come to market

How to Cash in on the Fight Against the Zika Virus

How to Cash in on the Fight Against the Zika Virus

Where some see danger and upheaval, investors see opportunity. And the harrowing Zika virus is no different. Investors are jumping into stocks focused on detecting or wiping out the virus.